MediciNova, Inc. (4875.T)

JPY 214.0

(0.47%)

Gross Profit Summary of MediciNova, Inc.

  • MediciNova, Inc.'s latest annual gross profit in 2023 was 1 Million USD , down 0.0% from previous year.
  • MediciNova, Inc.'s latest quarterly gross profit in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • MediciNova, Inc. reported a annual gross profit of - USD in annual gross profit 2022, down -100.0% from previous year.
  • MediciNova, Inc. reported a annual gross profit of 4.03 Million USD in annual gross profit 2021, down 0.0% from previous year.
  • MediciNova, Inc. reported a quarterly gross profit of - USD for 2024 Q2, down 0.0% from previous quarter.
  • MediciNova, Inc. reported a quarterly gross profit of - USD for 2023 Q4, down -100.0% from previous quarter.

Annual Gross Profit Chart of MediciNova, Inc. (2023 - 2019)

Historical Annual Gross Profit of MediciNova, Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 1 Million USD 0.0%
2022 - USD -100.0%
2021 4.03 Million USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%

Peer Gross Profit Comparison of MediciNova, Inc.

Name Gross Profit Gross Profit Difference
KOHJIN BIO CO LTD 1.88 Billion JPY 99.947%
PRISM BioLab Co.,LTD 80.3 Million JPY 98.755%
GNI Group Ltd. 22.43 Billion JPY 99.996%
Linical Co., Ltd. 3.77 Billion JPY 99.974%
Trans Genic Inc. 2.24 Billion JPY 99.956%
MEDINET Co., Ltd. 98.25 Million JPY 98.982%
Soiken Holdings Inc. 2.48 Billion JPY 99.96%
Cytori Cell Research Institute, Inc. 1.29 Billion JPY 99.923%
AnGes, Inc. -3.06 Billion JPY 100.033%
OncoTherapy Science, Inc. -177.71 Million JPY 100.563%
Nxera Pharma Co., Ltd. 9.66 Billion JPY 99.99%
Immuno-Biological Laboratories Co., Ltd. 517.29 Million JPY 99.807%
NanoCarrier Co., Ltd. 110.95 Million JPY 99.099%
Carna Biosciences, Inc. 1.45 Billion JPY 99.931%
CanBas Co., Ltd. -984 Million JPY 100.102%
D. Western Therapeutics Institute, Inc. 391.69 Million JPY 99.745%
RaQualia Pharma Inc. 1.65 Billion JPY 99.94%
Chiome Bioscience Inc. 398.59 Million JPY 99.749%
Kidswell Bio Corporation 1.03 Billion JPY 99.904%
PeptiDream Inc. 17.21 Billion JPY 99.994%
Oncolys BioPharma Inc. 30.6 Million JPY 96.733%
Ribomic Inc. -10.5 Million JPY 109.522%
SanBio Company Limited -14.5 Million JPY 106.895%
Healios K.K. 108 Million JPY 99.074%
BrightPath Biotherapeutics Co., Ltd. -341 Thousand JPY 393.255%
Kubota Pharmaceutical Holdings Co., Ltd. -59.04 Million JPY 101.694%
Delta-Fly Pharma, Inc. -1.51 Million JPY 166.138%
StemRIM -44.34 Million JPY 102.255%
CellSource Co., Ltd. 3.18 Billion JPY 99.969%
FunPep Company Limited -680.28 Million JPY 100.147%
Kringle Pharma, Inc. 69.25 Million JPY 98.556%
Stella Pharma Corporation 217.29 Million JPY 99.54%
TMS Co., Ltd. -6.95 Million JPY 114.388%
Noile-Immune Biotech Inc. 314.56 Million JPY 99.682%
Cuorips Inc. 9.63 Million JPY 89.617%
K Pharma,Inc. 910 Million JPY 99.89%
Takara Bio Inc. 25.45 Billion JPY 99.996%
ReproCELL Incorporated 1.1 Billion JPY 99.909%
PhoenixBio Co., Ltd. 1.19 Billion JPY 99.916%
StemCell Institute Inc. 1.57 Billion JPY 99.937%
Japan Tissue Engineering Co., Ltd. 1.66 Billion JPY 99.94%
CellSeed Inc. 107.15 Million JPY 99.067%